Suzhou Ribo Life Science Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2019	FY 2018	FY 2017
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
Cash & Equivalents	183.62	212.35	238.12	105.11	216.5
Cash & Short-Term Investments	183.62	212.35	238.12	105.11	216.5
Cash Growth	-13.53%	-10.82%	126.55%	-51.45%	-
Accounts Receivable	3.47	0.01	-	-	-
Other Receivables	-	-	0.92	1.46	2.52
Receivables	3.47	0.01	0.92	1.46	2.52
Inventory	42.72	45.6	19.87	10.17	6.48
Other Current Assets	39.48	51.51	20.87	8.24	1
Total Current Assets	269.29	309.48	279.79	124.98	226.5
Property, Plant & Equipment	276.1	296.79	44.83	29.36	25.09
Long-Term Investments	-	-	-	-	1.31
Other Intangible Assets	92.47	108.42	88.49	99.86	3.05
Other Long-Term Assets	12.99	1.57	18.96	14.63	9.22
Total Assets	650.86	716.25	432.07	268.82	265.18
Accounts Payable	24.23	23.27	5.61	6.71	5.13
Accrued Expenses	1.24	-	12.33	7.09	4.36
Short-Term Debt	226.61	217.28	76.08	-	-
Current Portion of Leases	7.63	8.09	-	-	-
Current Income Taxes Payable	-	-	0.62	0.38	0.39
Current Unearned Revenue	67.12	-	12.28	10.27	18.97
Other Current Liabilities	87.48	79.22	2.93	2.09	1.34
Total Current Liabilities	414.31	327.85	109.85	26.53	30.18
Long-Term Debt	172.28	163.71	-	-	-
Long-Term Leases	22.36	25.66	-	-	-
Long-Term Unearned Revenue	89.7	24.15	0.88	1.64	2.44
Other Long-Term Liabilities	63.28	59.16	9.75	-	-
Total Liabilities	761.93	600.53	120.49	28.17	32.62
Common Stock	129.61	128.39	29.81	27.04	24.5
Additional Paid-In Capital	-	-	683.49	480.52	375.7
Retained Earnings	-	-	-400.37	-266.01	-167.35
Comprehensive Income & Other	-239.97	-23.28	-	-	-
Total Common Equity	-110.36	105.1	312.93	241.55	232.84
Minority Interest	-0.71	10.62	-1.35	-0.9	-0.29
Shareholders' Equity	-111.07	115.72	311.58	240.65	232.55
Total Liabilities & Equity	650.86	716.25	432.07	268.82	265.18
Total Debt	428.88	414.74	76.08	-	-
Net Cash (Debt)	-245.26	-202.39	162.04	105.11	216.5
Net Cash Growth	-	-	54.16%	-51.45%	-
Net Cash Per Share	-1.91	-1.58	5.44	3.89	8.84
Filing Date Shares Outstanding	128.9	128.25	29.81	27.04	24.5
Total Common Shares Outstanding	128.9	128.25	29.81	27.04	24.5
Working Capital	-145.01	-18.38	169.94	98.45	196.32
Book Value Per Share	-0.86	0.82	10.50	8.93	9.50
Tangible Book Value	-202.83	-3.32	224.45	141.69	229.79
Tangible Book Value Per Share	-1.57	-0.03	7.53	5.24	9.38
Machinery	-	-	71.13	48.46	38.78

Source: S&P Global Market Intelligence. Standard template. Financial Sources.